Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Common Equity (2020 - 2025)

iHuman has reported Common Equity over the past 6 years, most recently at $140.3 million for Q4 2025.

  • Quarterly Common Equity rose 4.89% to $140.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $140.3 million through Dec 2025, up 4.89% year-over-year, with the annual reading at $142.3 million for FY2025, 8.11% up from the prior year.
  • Common Equity was $140.3 million for Q4 2025 at iHuman, up from $133.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $140.3 million in Q4 2025 and troughed at $95.2 million in Q4 2021.
  • The 5-year median for Common Equity is $133.0 million (2023), against an average of $122.1 million.
  • Biggest five-year swings in Common Equity: fell 1.87% in 2021 and later grew 22.96% in 2023.
  • Tracing IH's Common Equity over 5 years: stood at $95.2 million in 2021, then grew by 13.7% to $108.2 million in 2022, then grew by 22.96% to $133.0 million in 2023, then grew by 0.55% to $133.8 million in 2024, then rose by 4.89% to $140.3 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $140.3 million, $133.8 million, and $133.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.